Gene Silencing of Transferrin-1 Receptor as a Potential Therapeutic Target for Human Follicular and Anaplastic Thyroid Cancer

van Staveren, 2007, Human thyroid tumor cell lines derived from different tumor types present a common dedifferentiated phenotype, Cancer Res., 67, 8113, 10.1158/0008-5472.CAN-06-4026 Anabousi, 2006, In vitro assessment of transferrin-conjugated liposomes as drug delivery systems for inhalation therapy of lung cancer, Eur. J. Pharm. Sci., 29, 367, 10.1016/j.ejps.2006.07.004 Chiotoglou, 2008, Predominantly post-transcriptional regulation of activation molecules in chronic lymphocytic leukemia: the case of transferrin receptors, Blood Cells Mol. Dis., 41, 203, 10.1016/j.bcmd.2008.05.003 Beguin, 1992, Erythropoiesis in multiple myeloma: defective red cell production due to inappropriate erythropoietin production, Br. J. Haematol., 82, 648, 10.1111/j.1365-2141.1992.tb06939.x Hartford, 1993, Utilization of transferrin-bound iron by Listeria monocytogenes, FEMS Microbiol. Lett., 108, 311, 10.1111/j.1574-6968.1993.tb06121.x Lawrence, 1999, Crystal structure of the ectodomain of human transferrin receptor, Science, 286, 779, 10.1126/science.286.5440.779 Bennett, 2000, Crystal structure of the hereditary haemochromatosis protein HFE complexed with transferrin receptor, Nature, 403, 46, 10.1038/47417 Rao, 1985, Effects of alterations in cellular iron on biosynthesis of the transferrin receptor in K562 cells, Mol. Cell. Biol., 5, 595, 10.1128/MCB.5.4.595 Cheng, 2004, Structure of the human transferrin receptor-transferrin complex, Cell, 116, 565, 10.1016/S0092-8674(04)00130-8 Bianchi, 1999, HIF-1-mediated activation of transferrin receptor gene transcription by iron chelation, Nucleic Acids Res., 27, 4223, 10.1093/nar/27.21.4223 Klausner, 1993, Regulating the fate of mRNA: the control of cellular iron metabolism, Cell, 72, 19, 10.1016/0092-8674(93)90046-S Hentze, 1996, Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress, Proc. Natl. Acad. Sci. USA, 93, 8175, 10.1073/pnas.93.16.8175 Hsing, 1995, Cancer risk following primary hemochromatosis: a population-based cohort study in Denmark, Int. J. Cancer, 60, 160, 10.1002/ijc.2910600204 Goldstein, 1998, Studies of iron deposits, inducible nitric oxide synthase and nitrotyrosine in a rat model for esophageal adenocarcinoma, Carcinogenesis, 19, 1445, 10.1093/carcin/19.8.1445 Chen, 1999, An esophagogastroduodenal anastomosis model for esophageal adenocarcinogenesis in rats and enhancement by iron overload, Carcinogenesis, 20, 1801, 10.1093/carcin/20.9.1801 Chen, 2001, Esophageal adenocarcinoma: a review and perspectives on the mechanism of carcinogenesis and chemoprevention, Carcinogenesis, 22, 1119, 10.1093/carcin/22.8.1119 Miskimins, 1985, Use of a protein-blotting procedure and a specific DNA probe to identify nuclear proteins that recognize the promoter region of the transferrin receptor gene, Proc. Natl. Acad. Sci. USA, 82, 6741, 10.1073/pnas.82.20.6741 Testa, 1993, The transferrin receptor, Crit. Rev. Oncog., 4, 241 Cavanaugh, 2002, Synthesis of chlorin e6-transferrin and demonstration of its light-dependent in vitro breast cancer cell killing ability, Breast Cancer Res. Treat., 72, 117, 10.1023/A:1014811915564 O’Donnell, 2006, Activation of transferrin receptor 1 by c-Myc enhances cellular proliferation and tumorigenesis, Mol. Cell. Biol., 26, 2373, 10.1128/MCB.26.6.2373-2386.2006 Iritani, 1999, c-Myc enhances protein synthesis and cell size during B lymphocyte development, Proc. Natl. Acad. Sci. USA, 96, 13180, 10.1073/pnas.96.23.13180 Kasibhatla, 2005, A role for transferrin receptor in triggering apoptosis when targeted with gambogic acid, Proc. Natl. Acad. Sci. USA, 102, 12095, 10.1073/pnas.0406731102 Xing, 2003, Methylation of the thyroid-stimulating hormone receptor gene in epithelial thyroid tumors: a marker of malignancy and a cause of gene silencing, Cancer Res., 63, 2316 Stenner, 2008, Targeted therapeutic approach for an anaplastic thyroid cancer in vitro and in vivo, Cancer Sci., 99, 1847 Wang, 2017, [The efficacy of thyroid hormone replacement therapy in patients with hypothyroidism and OSAHS: a meta analysis], Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, 31, 1362 Gianì, 2019, Computational modeling reveals MAP3K8 as mediator of resistance to vemurafenib in thyroid cancer stem cells, Bioinformatics, 35, 2267, 10.1093/bioinformatics/bty969 Cairo, 2000, Iron regulatory proteins in pathobiology, Biochem. J., 352, 241, 10.1042/bj3520241 Habel, 2006, Free radicals act as effectors in the growth inhibition and apoptosis of iron-treated Burkitt’s lymphoma cells, Free Radic. Res., 40, 789, 10.1080/10715760500484344 Chiacchio, 2013, Synthesis and biological evaluation of 1,7,8,8a-tetrahydro-3H-oxazolo[3,4-a]pyrazin-6(5H)-ones as antitumoral agents, Bioorg. Med. Chem., 21, 5748, 10.1016/j.bmc.2013.07.019 Campisi, 2003, Glutamate-induced increases in transglutaminase activity in primary cultures of astroglial cells, Brain Res., 978, 24, 10.1016/S0006-8993(03)02725-2 Mosmann, 1983, Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays, J. Immunol. Methods, 65, 55, 10.1016/0022-1759(83)90303-4 Campisi, 2004, Glutamate-evoked redox state alterations are involved in tissue transglutaminase upregulation in primary astrocyte cultures, FEBS Lett., 578, 80, 10.1016/j.febslet.2004.10.074 Campisi, 2012, Expression of tissue transglutaminase on primary olfactory ensheathing cells cultures exposed to stress conditions, Neurosci. Res., 72, 289, 10.1016/j.neures.2011.12.008 Campisi, 2010, Reactive oxygen species levels and DNA fragmentation on astrocytes in primary culture after acute exposure to low intensity microwave electromagnetic field, Neurosci. Lett., 473, 52, 10.1016/j.neulet.2010.02.018